Los puntos clave no están disponibles para este artículo en este momento.
Outcomes in patients with hormone receptor-positive metastatic breast cancer worsen after one or more lines of endocrine-based therapy. Trastuzumab deruxtecan has shown efficacy in patients with metastatic breast cancer with low expression of human epidermal growth factor receptor 2 (HER2) after previous chemotherapy.
Building similarity graph...
Analyzing shared references across papers
Loading...
Aditya Bardia
Xichun Hu
Rebecca Dent
New England Journal of Medicine
Harbin Medical University
Fudan University Shanghai Cancer Center
National Cancer Center
Building similarity graph...
Analyzing shared references across papers
Loading...
Bardia et al. (Sat,) studied this question.
www.synapsesocial.com/papers/68e587feb6db643587524983 — DOI: https://doi.org/10.1056/nejmoa2407086
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: